Insider · CIK 0001606833

CALSADA CRISPINA

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001606833

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−140K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−21K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−15K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−48K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−45K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−375K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−85K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−462K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−563K sh	—	—	0
2025-01-30	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+563K sh	—	—	562,500
2025-01-14	Regulus Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−5,088 sh	$1.26	−$6,427.162	45,478
2025-01-13	Regulus Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−38.7K sh	$1.26	−$48.9K	50,566
2025-01-09	Regulus Therapeutics Inc.A Award	Chief Financial Officer	AAward	+62.5K sh	$1.36	+$85K	68,282
2025-01-09	Regulus Therapeutics Inc.A Award	Chief Financial Officer	AAward	+21K sh	$1.30	+$27.3K	89,282
2024-05-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+462K sh	—	—	462,000
2024-01-18	Regulus Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−5,468 sh	$1.19	−$6,510.201	5,782
2024-01-12	Regulus Therapeutics Inc.A Award	Chief Financial Officer	AAward	+11.3K sh	—	—	11,250
2024-01-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+85K sh	—	—	85,000
2023-08-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+375K sh	—	—	375,000
2023-01-11	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2022-05-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2022-01-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+480K sh	—	—	480,000
2021-02-04	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2020-01-22	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2019-10-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+210K sh	—	—	210,000
2019-08-30	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Jun 274
CALSADA CRISPINA0000950170-25-090986
SEC(opens sec.gov)
Jan 314
CALSADA CRISPINA0000950170-25-011848
SEC(opens sec.gov)
Jan 154
CALSADA CRISPINA0000950170-25-005881
SEC(opens sec.gov)
Jan 104
CALSADA CRISPINA0000950170-25-004272
SEC(opens sec.gov)
May 214
CALSADA CRISPINA0000950170-24-062918
SEC(opens sec.gov)
Jan 184
CALSADA CRISPINA0001209191-24-001875
SEC(opens sec.gov)
Jan 174
CALSADA CRISPINA0001209191-24-001775
SEC(opens sec.gov)

Companies

Regulus Therapeutics Inc.Chief Financial Officer

Address

C/O REGULUS THERAPEUTICS INC. 4224 CAMPUS POINT CT., #210

SAN DIEGO, CA, 92121